SEP 11, 2019 6:00 AM PDT

Find out how GARDP is redoubling its efforts to accelerate the development and delivery of new and improved antibiotics

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • BMed Sci, BMBS, DTM&H, MSc, FRCP, Executive Director, GARDP
    Biography
      Dr Manica Balasegaram is GARDP's Executive Director and has been instrumental in leading GARDP through its three-year incubation to an independent legal entity, during which time GARDP launched four programmes and built a skilled and dedicated team with expertise from a range of sectors and backgrounds.
      Manica trained as a medical doctor at the University of Nottingham, UK from where he started his career in internal and emergency medicine. From 2001 onwards, he worked as a doctor and researcher in several countries in Sub- Saharan Africa and Southern Asia. He also gained significant experience working in humanitarian emergencies and responses, largely with Médecins Sans Frontières (MSF). At the end of 2007 he joined the Drugs for Neglected Diseases initiative as Head of Leishmaniasis Clinical Program - a position he held for four years before returning to MSF as Executive Director of their Access Campaign. He joined GARDP in June 2016 and is currently a board member of the Medicines Patent Pool as well as of FIND's Scientific Advisory Committee. Manica's experience spans clinical and public health practice in infectious diseases and international work on health policy & access to medicines. He has served on numerous technical and health policy panels and expert groups. He also has substantial experience in conducting and overseeing clinical trials and drug development projects.

    Abstract

    Antibiotics have radically transformed our world by making previously incurable illnesses treatable. Millions of lives have been saved and our wellbeing significantly improved as a result. This remarkable progress is threatened by the spread of antibiotic resistance and requires an urgent global response. In this webinar, Dr Manica Balasegaram, GARDP’s Executive Director shares GARDP’s goal to accelerate the development and delivery of five new and improved treatments by 2025 to address antibiotic-resistant infections that pose the greatest threat to health and development.


    Show Resources
    You May Also Like
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    DEC 16, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 16, 2020 8:00 AM PST
    Date: December 16, 2020 Time: 8:00am (PST), 11:00am (EST) Molecular imaging of living specimens offers a means to draw upon the growing body of high-throughput molecular data to better under...
    NOV 10, 2020 7:00 AM PST
    C.E. CREDITS
    NOV 10, 2020 7:00 AM PST
    DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
    SEP 11, 2019 6:00 AM PDT

    Find out how GARDP is redoubling its efforts to accelerate the development and delivery of new and improved antibiotics

    C.E. Credits: P.A.C.E. CE Florida CE

    Specialty

    Molecular Biology

    Animal Research

    Biomarkers

    Diagnostics

    Protein

    Brain

    Animal Models

    Health

    Pcr/rt-Pcr/real-Time Pcr

    Dna

    Animal Sciences

    Clinical Diagnostics

    Gene Expression

    Neuroscience

    Infectious Disease

    Geography

    Asia60%

    Registration Source

    Website Visitors100%

    Job Title

    Educator/Faculty67%

    Medical Laboratory Technician33%

    Organization

    Academic Institution40%

    Hospital20%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more